Literature DB >> 21233534

Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acids.

Paul C Trippier1, Jan Balzarini, Christopher McGuigan.   

Abstract

BACKGROUND: carbohydrate-binding agents are considered as potential therapeutic agents for the inhibition of highly glycosylated enveloped viruses such as HIV type-1. Phenylboronic acids are well-known to bind the cis-diol functionality of carbohydrate structures, thereby identifying themselves as potential lead structures.
METHODS: bisphenylboronic acids connected via a functionalized linker at variable length (1-13 atoms) bearing the binding boronic acid functionality at the three possible ring geometries relative to the linker have been investigated as probes for selective and non-selective saccharide sensors. Herein, we describe the compilation of a 'linker-diverse' compound library of bisphenylboronic acids and the determination of the structure-activity relationship versus a variety of enveloped viruses. Molecular modelling of the gp120 glycans of simian immunodeficiency virus was undertaken to ascertain a theoretical minimum length of the linker unit.
RESULTS: the compounds demonstrated no pronounced antiviral activity. The general low toxicity of the boronic acids became evident in this study, thereby justifying further studies.
CONCLUSIONS: a higher concentration of phenylboronate functional groups per molecule, resulting in multivalency, might be necessary to bind with sufficient potency to HIV type-1 gp120 and to elicit an antiviral action.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233534     DOI: 10.3851/IMP1707

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  4 in total

1.  Monosubstituted Phenylboronic Acids, R-B(OH)2 (R = C6H5, C6H4CH3, C6H4NH2, C6H4OH, and C6H4F): A Computational Investigation.

Authors:  Niny Z Rao; Joseph D Larkin; Charles W Bock
Journal:  Struct Chem       Date:  2016-12-15       Impact factor: 1.887

2.  Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.

Authors:  Kshitij Verma; Tianzhu Zang; Trevor M Penning; Paul C Trippier
Journal:  J Med Chem       Date:  2019-03-25       Impact factor: 7.446

3.  Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus.

Authors:  Aleksandra Łoczechin; Karin Séron; Alexandre Barras; Emerson Giovanelli; Sandrine Belouzard; Yen-Ting Chen; Nils Metzler-Nolte; Rabah Boukherroub; Jean Dubuisson; Sabine Szunerits
Journal:  ACS Appl Mater Interfaces       Date:  2019-11-06       Impact factor: 9.229

Review 4.  Molecular architecture and therapeutic potential of lectin mimics.

Authors:  Yu Nakagawa; Ito Yukishige
Journal:  Adv Carbohydr Chem Biochem       Date:  2012       Impact factor: 12.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.